Anna Cuppari

Anna Cuppari

Auto-generated profile, based on publicly available information

Anna Cuppari

Experiments Division, ALBA Synchrotron Light Source, Carrer de la Llum 2–26, 08290 Cerdanyola del Vallès, Catalunya, Spain

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TGTheodoros Goulas
Theodoros Goulas
ACAnna Cuppari
Anna Cuppari
RGRaquel Garcia-Castellanos
Raquel Garcia-Castellanos
SSScott Snipas
Scott Snipas
RGRudi Glockshuber
Rudi Glockshuber
FGF. Xavier Gomis-Rüth
F. Xavier Gomis-Rüth
A major bottleneck in structural, biochemical and biophysical studies of proteins is the need for large amounts of pure homogenous material, which is generally obtained by recombinant overexpression. Here we introduce a vector collection, the pCri System, for cytoplasmic and periplasmic/extracellular expression of heterologous proteins that allows the simultaneous assessment of prokaryotic and eukaryotic host cells (Escherichia coli, Bacillus subtilis, and Pichia pastoris). By using a single polymerase chain reaction product, genes of interest can be directionally cloned in all vectors within four different rare restriction sites at the 5′end and multiple cloning sites at the 3′end. In this way, a number of different fusion tags but also signal peptides can be incorporated at the N- and C-terminus of proteins, facilitating their expression, solubility and subsequent detection and purification. Fusion tags can be efficiently removed by treatment with site-specific peptidases, such as tobacco etch virus proteinase, thrombin, or sentrin specific peptidase 1, which leave only a few extra residues at the N-terminus of the protein. The combination of different expression systems in concert with the cloning approach in vectors that can fuse various tags makes the pCri System a valuable tool for high throughput studies.

18 May 2018 in Chemical Reviews
Verified
Journal Article
Closed access
JAJoan L. Arolas
Joan L. Arolas
TGTheodoros Goulas
Theodoros Goulas
ACAnna Cuppari
Anna Cuppari
FGF. Xavier Gomis-Rüth
F. Xavier Gomis-Rüth

9 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SLSébastien Lyonnais
Sébastien Lyonnais
ATAleix Tarrés-Solé
Aleix Tarrés-Solé
ARAnna Rubio-Cosials
Anna Rubio-Cosials
ACAnna Cuppari
Anna Cuppari
RBReicy Brito
Reicy Brito
MSMaria Solà
Maria Solà
The ability of the guanine-rich strand of the human mitochondrial DNA (mtDNA) to form G-quadruplex structures (G4s) has been recently highlighted, suggesting potential functions in mtDNA replication initiation and mtDNA stability. G4 structures in mtDNA raise the question of their recognition by factors associated with the mitochondrial nucleoid. The mitochondrial transcription factor A (TFAM), a high-mobility group (HMG)-box protein, is the major binding protein of human mtDNA and plays a critical role in its expression and maintenance. HMG-box proteins are pleiotropic sensors of DNA structural alterations. Thus, we investigated and uncovered a surprising ability of TFAM to bind to DNA or RNA G4 with great versatility, showing an affinity similar than to double-stranded DNA. The recognition of G4s by endogenous TFAM was detected in mitochondrial extracts by pull-down experiments using a G4-DNA from the mtDNA conserved sequence block II (CSBII). Biochemical characterization shows that TFAM binding to G4 depends on both the G-quartets core and flanking single-stranded overhangs. Additionally, it shows a structure-specific binding mode that differs from B-DNA, including G4-dependent TFAM multimerization. These TFAM-G4 interactions suggest functional recognition of G4s in the mitochondria.

22 May 2019 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
ACAnna Cuppari
Anna Cuppari
PFPablo Fernández-Millán
Pablo Fernández-Millán
FBFederica Battistini
Federica Battistini
ATAleix Tarrés-Solé
Aleix Tarrés-Solé
SLSébastien Lyonnais
Sébastien Lyonnais
MSMaria Solà
Maria Solà
Human mitochondrial DNA (h-mtDNA) codes for 13 subunits of the oxidative phosphorylation pathway, the essential route that produces ATP. H-mtDNA transcription and replication depends on the transcription factor TFAM, which also maintains and compacts this genome. It is well-established that TFAM activates the mtDNA promoters LSP and HSP1 at the mtDNA control region where DNA regulatory elements cluster. Previous studies identified still uncharacterized, additional binding sites at the control region downstream from and slightly similar to LSP, namely sequences X and Y (Site-X and Site-Y) (Fisher et al., Cell 50, pp 247–258, 1987). Here, we explore TFAM binding at these two sites and compare them to LSP by multiple experimental and in silico methods. Our results show that TFAM binding is strongly modulated by the sequence-dependent properties of Site-X, Site-Y and LSP. The high binding versatility of Site-Y or the considerable stiffness of Site-X tune TFAM interactions. In addition, we show that increase in TFAM/DNA complex concentration induces multimerization, which at a very high concentration triggers disruption of preformed complexes. Therefore, our results suggest that mtDNA sequences induce non-uniform TFAM binding and, consequently, direct an uneven distribution of TFAM aggregation sites during the essential process of mtDNA compaction.

28 February 2019 in IUCrJ
Verified
Journal Article
Open access
PDF file
ACAnna Cuppari
Anna Cuppari
HKHagen Körschgen
Hagen Körschgen
DFDirk Fahrenkamp
Dirk Fahrenkamp
CSCarlo Schmitz
Carlo Schmitz
TGTibisay Guevara
Tibisay Guevara
FGF. Xavier Gomis-Rüth
F. Xavier Gomis-Rüth
Mammalian fetuin-A and fetuin-B are abundant serum proteins with pleiotropic functions. Fetuin-B is a highly selective and potent inhibitor of metallopeptidases (MPs) of the astacin family, which includes ovastacin in mammals. By inhibiting ovastacin, fetuin-B is essential for female fertility. The crystal structure of fetuin-B was determined unbound and in complex with archetypal astacin, and it was found that the inhibitor has tandem cystatin-type modules (CY1 and CY2). They are connected by an exposed linker with a rigid, disulfide-linked `CPDCP-trunk', and are followed by a C-terminal region (CTR) with little regular secondary structure. The CPDCP-trunk and a hairpin of CY2 form a bipartite wedge, which slots into the active-site cleft of the MP. These elements occupy the nonprimed and primed sides of the cleft, respectively, but spare the specificity pocket so that the inhibitor is not cleaved. The aspartate in the trunk blocks the catalytic zinc of astacin, while the CY2 hairpin binds through a QWVXGP motif. The CY1 module assists in structural integrity and the CTR is not involved in inhibition, as verified byin vitrostudies using a cohort of mutants and variants. Overall, the inhibition conforms to a novel `raised-elephant-trunk' mechanism for MPs, which is reminiscent of single-domain cystatins that target cysteine peptidases. Over 200 sequences from vertebrates have been annotated as fetuin-B, underpinning its ubiquity and physiological relevance; accordingly, sequences with conserved CPDCP- and QWVXGP-derived motifs have been found from mammals to cartilaginous fishes. Thus, the raised-elephant-trunk mechanism is likely to be generally valid for the inhibition of astacins by orthologs of fetuin-B.

1 May 2018 in Biophysical Journal
Verified
Journal Article
Closed access
ARAnna Rubio-Cosials
Anna Rubio-Cosials
FBFederica Battistini
Federica Battistini
AGAlexander Gansen
Alexander Gansen
ACAnna Cuppari
Anna Cuppari
Pau BernadoPau Bernado
Pau Bernado
MSMaria Solà
Maria Solà